EXHIBIT 99.1
USANA Reports Record Results for the Third Quarter
SALT LAKE CITY--(BUSINESS WIRE)--Oct. 19, 2004--USANA Health
Sciences Inc. (NASDAQ:USNA)
-- Net Sales up 30.8%
-- EPS up 39.3%
-- Record Operating Margin
-- Company provides preliminary 2005 guidance
USANA Health Sciences Inc. (NASDAQ:USNA) today announced record
net sales of $68.7 million for the third quarter ended Oct. 2, 2004.
Net sales for the period increased 30.8% from $52.5 million in the
third quarter of 2003. The company reported record operating income
for the quarter of $12.1 million, compared to $8.5 million in the
third quarter of 2003. The company also achieved record operating
margin of 17.7% in the third quarter, compared to 16.2% in third
quarter of 2003.
Net earnings in the third quarter were $8.0 million, up 32.0% from
$6.1 million in the third quarter of 2003. Earnings per share
increased in the third quarter to $0.39 per share, up 39.3% from $0.28
per share for the third quarter of 2003. This $0.39 earnings per share
includes a $0.01 increase from the one-time use of Research and
Development tax credits and a $0.02 decrease due to foreign currency
fluctuations.
USANA's total number of active Associates increased in the third
quarter of 2004 to 111,000, up 27.6% from 87,000 in the third quarter
of 2003. Preferred Customers increased to 60,000 in the quarter, up
22.4% from 49,000 in the third quarter of 2003.
For the nine-month period ended Oct. 2, 2004, net sales were
$197.7 million, up 40.7% from $140.5 million in the same period of
2003. Net earnings for that nine-month period were $21.6 million, up
54.7% from $14 million for the same period of 2003. Earnings per share
for the current nine-month period were $1.05, up 59.1% from $0.66 for
the same period of 2003.
"The U.S. market continues to lead the way," said Dave Wentz,
USANA's president, "with net sales growth of 23% compared to the third
quarter of last year. Canada reported strong net sales in the quarter,
up nearly 17% over last year's third quarter. The number of active
Associates worldwide grew 27.6% compared to last year, reflecting our
continued effort to recognize, develop and support our sales leaders.
We're pleased with the consistent growth our company has been able to
generate during the past two years, and we believe we are well
positioned to grow in 2005."
Another highlight of the quarter was USANA's annual international
convention held in Salt Lake City in mid-September. The September
convention marked the largest gathering of USANA Associates ever held.
The company announced the re-formulation of Sense(TM), its innovative
and popular skin and personal care product line.
"We took another step forward to solidify our position in the skin
and personal care industry through the recent launch of the new Sense
line," continued Wentz. "Our new patent-pending, self-preserving
technology allows our products to be formulated without adding
parabens. We believe we now have a line of skin and personal care
products that will attract a new category of Associates who are
focused on building a home-based business with Sense.
"The enthusiasm and excitement for the new Sense products among
the Associates during the convention was tremendous. Due to higher
than anticipated demand for Sense, some of our products sold out, and
we were not able to ship all of the orders before the end of the third
quarter. In response to this, we have increased production at our
Wasatch facility to meet the demand. Over the next several weeks, we
will continue launching our new, innovative Sense products in each of
our international markets."
Commenting on USANA's financial performance, Gilbert A. Fuller,
chief financial officer, noted, "The third quarter marked the ninth
consecutive quarter of record sales. We achieved year-over-year
double-digit growth in all our markets except South Korea. Our largest
market, the U.S., continued to excel, with sales of $28.8 million,
compared to $23.4 million in the third quarter of 2003. Operating
margin in the quarter improved 150 basis points to 17.7%, compared to
last year's third quarter. We continue to gain incremental operating
leverage through top-line growth and internal cost controls.
"Looking ahead to the remainder of 2004," continued Fuller, "we
still expect net sales for full year 2004 to approach $270 million. We
previously announced that we expected earnings per share for the full
year 2004 of $1.42 to $1.44. Now we expect that earnings per share for
the full year will be as much as $1.46.
"As we take our first look at 2005," Fuller continued, "we believe
that net sales will grow between 15% and 18%, which includes revenue
from the proposed opening of one new market before the end of the
third quarter of 2005. We expect earnings per share in 2005 to grow
between 20% and 25%. These preliminary 2005 estimates exclude any
sales from our potential entry into China. Our time frame for opening
China remains uncertain because the regulations that will govern
network marketing in the region have not yet been finalized."
USANA executives will hold a conference call and live webcast to
discuss this announcement with investors on Oct. 20, 2004, at 11 a.m.
EDT. Investors may listen to the call by accessing USANA's Web site at
http://www.usanahealthsciences.com and by clicking on the "Investors"
icon.
About USANA
USANA develops and manufactures high-quality nutritional and
personal care products that are sold directly to Associates and
Preferred Customers throughout the United States, Canada, Australia,
New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico,
the Netherlands and the United Kingdom. More information on USANA can
be found at http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act and Section 21E of the
Securities Exchange Act. Actual results could differ materially from
those projected in the forward-looking statements, which involve a
number of risks and uncertainties, including reliance upon the
company's independent Associate network, government regulation of
products, manufacturing and marketing, and risks associated with
international expansion. The contents of this release should be
considered in conjunction with the risk factors, warnings and
cautionary statements contained in USANA's most recent filings with
the Securities and Exchange Commission.
USANA Health Sciences Inc.
Consolidated Statements of Earnings
(in thousands, except per share data)
Quarter Ended Nine Months Ended
--------------------- ----------------------
Sept. 27, Oct 2, Sept. 27, Oct. 2,
2003 2004 2003 2004
---------- ---------- ---------- -----------
(Unaudited)(Unaudited)(Unaudited)(Unaudited)
Net sales $52,506 $68,673 $140,527 $197,694
Cost of sales 11,364 16,732 31,001 47,985
---------- ---------- ---------- -----------
Gross profit 41,142 51,941 109,526 149,709
Operating expenses
Associate incentives 20,332 26,210 55,091 75,378
Selling, general and
administrative 11,926 13,141 32,072 40,059
Research and
development 379 450 1,086 1,635
---------- ---------- ---------- -----------
Earnings from
operations 8,505 12,140 21,277 32,637
Other income (expense) 525 (513) 331 (365)
---------- ---------- ---------- -----------
Earnings before
income taxes 9,030 11,627 21,608 32,272
Income taxes 2,974 3,631 7,628 10,650
---------- ---------- ---------- -----------
NET EARNINGS $6,056 $7,996 $13,980 $21,622
========== ========== ========== ===========
Earnings per share -
diluted $0.28 $0.39 $0.66 $1.05
========== ========== ========== ===========
Weighted average shares
outstanding - diluted 21,383 20,296 21,294 20,557
========== ========== ========== ===========
USANA Health Sciences Inc.
Consolidated Balance Sheets
(in thousands)
As of As of
Jan. 3, 2004 Oct. 2, 2004
------------ ------------
(Unaudited)
ASSETS
Cash and cash equivalents $18,965 $21,445
Inventories 14,069 16,195
Other current assets 5,215 5,669
---------- ----------
Total current assets 38,249 43,309
Property and equipment, net 20,195 23,689
Goodwill 4,267 5,690
Other assets 2,416 2,597
---------- ----------
Total assets $65,127 $75,285
========== ==========
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable $5,215 $8,029
Other current liabilities 14,704 18,618
---------- ----------
Total current liabilities 19,919 26,647
Other long-term liabilities 837 911
Stockholders' equity 44,371 47,727
---------- ----------
Total liabilities and
stockholders' equity $65,127 $75,285
USANA Health Sciences Inc.
Sales by Market
(in thousands)
Quarter Ended
-----------------------------------
Sept. 27, 2003 Oct. 2, 2004
----------------- -----------------
(Unaudited) (Unaudited)
Region
United States $23,444 44.7% $28,827 42.0%
Canada 10,770 20.5% 12,553 18.3%
Australia-New Zealand 8,023 15.3% 9,056 13.2%
Hong Kong 2,285 4.4% 2,837 4.1%
Japan 1,750 3.3% 2,356 3.4%
Taiwan 3,507 6.7% 3,903 5.7%
Korea 2,071 3.9% 1,366 2.0%
Singapore - 0.0% 2,678 3.9%
Mexico - 0.0% 2,268 3.3%
Wasatch 656 1.2% 2,829 4.1%
---------- ------ ---------- ------
$52,506 100.0% $68,673 100.0%
========== ====== ========== ======
Active Associates by Market
As of
-----------------------------------
Sept. 27, 2003 Oct. 2, 2004
----------------- -----------------
(Unaudited) (Unaudited)
Region
United States 33,000 37.9% 43,000 38.8%
Canada 19,000 21.8% 21,000 18.9%
Australia-New Zealand 14,000 16.1% 14,000 12.6%
Hong Kong 4,000 4.6% 5,000 4.5%
Japan 3,000 3.5% 5,000 4.5%
Taiwan 9,000 10.3% 8,000 7.2%
Korea 5,000 5.8% 3,000 2.7%
Singapore - 0.0% 6,000 5.4%
Mexico - 0.0% 6,000 5.4%
--------- ------ --------- ------
87,000 100.0% 111,000 100.0%
========= ====== ========= ======
Active Preferred Customers by Market
As of
-----------------------------------
Sept. 27, 2003 Oct. 2, 2004
----------------- -----------------
(Unaudited) (Unaudited)
Region
United States 30,000 61.2% 36,000 60.0%
Canada 14,000 28.6% 16,000 26.6%
Australia-New Zealand 4,000 8.2% 5,000 8.3%
Hong Kong 1,000 2.0% 1,000 1.7%
Japan (a) 0.0% (a) 0.0%
Taiwan (a) 0.0% 1,000 1.7%
Korea (a) 0.0% (a) 0.0%
Singapore 0.0% (a) 0.0%
Mexico 0.0% 1,000 1.7%
--------- ------ --------- ------
49,000 100.0% 60,000 100.0%
========= ====== ========= ======
(a) Count of Active Preferred Customers is less than 500.
CONTACT: USANA Health Sciences Inc., Salt Lake City
Riley Timmer, 801-954-7100
investor.relations@us.usana.com